Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...

ST. GEORGE, S.C. (WCIV) — A local nail technician is helping an effort to treat cancer patients to surprise make-overs.

Doctors are hoping a clinical trial at Harris Health Ben Taub will prove the treatment works and it’s worth getting ...

A grandmother diagnosed with an incurable cancer almost a decade ago has praised a “wonderful” new clinical trial for keeping her symptoms at bay. Jayne Stokes, 67, who lives near Dover, only ...

A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.

Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, aims to set new efficiency standards in the industry, to prove that ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...

Data presented at key congresses in North America and EuropeCAMBRIDGE, United Kingdom, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Microbiotica, a cl ...

Having only raised 5% of the R1.3 million that is desperately needed to administer the first course of immunotherapy to treat ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) today announced the availability of SELARSDI™ (ustekinumab-aekn) ...